Strategic Partnerships OXGENE's strategic partnerships with companies like Wugen Inc. and Fujifilm Diosynth present potential cross-selling opportunities for complementary services or technologies in the field of gene therapy.
Acquisition Synergies The acquisition by WuXi AppTec enhances OXGENE's capabilities, creating possibilities for expanded offerings and integrated solutions that can be positioned as value-added propositions to clients in the biotechnology sector.
Innovative Product Launch The launch of the self-labelling integral membrane protein discovery system showcases OXGENE's innovative product development. This new technology can be a focal point for sales discussions with clients seeking cutting-edge solutions in biologics manufacturing.
Technology Platforms Development OXGENE's focus on developing novel technology platforms opens doors for discussing partnership opportunities with companies looking to leverage advanced gene editing and antibody therapeutic technologies to enhance their product portfolios.
Market Expansion Potential With revenue ranging between $10M - $50M, OXGENE exhibits financial stability and growth potential. This provides a strong foundation for exploring new market segments and scaling sales operations effectively.
$1B
$50M$100M
$10M$50M
$10M$50M
$10M$50M
$10M$50M
$100M$1B
$10M$50MOXGENE uses 8 technology products and services including Salesforce, Font Awesome, Modernizr, and more. Explore OXGENE's tech stack below.
| OXGENE Email Formats | Percentage |
| FLast@oxgene.com | 48% |
| Last@oxgene.com | 3% |
| First.Last@oxgene.com | 1% |
| FLast@oxgene.com | 48% |
Biotechnology ResearchOxfordshire, United Kingdom51-200 Employees
OXGENE, a WuXi Advanced Therapies (WuXi ATU) company, based in Oxford, UK, provides cell and gene therapy pioneers around the world with the technologies, automation platforms and service solutions they need to come first in the race to deliver ground-breaking therapeutics. OXGENE™ is headquartered in Oxford, UK. For additional information, please visit our website.
Company Overview
Media & News
Funding & FinancialsOXGENE has raised a total of $8.6M of funding over 6 rounds. Their latest funding round was raised on Apr 03, 2019 in the amount of $8.6M.
OXGENE's revenue is in the range of $10M$50M
Funding & FinancialsOXGENE has raised a total of $8.6M of funding over 6 rounds. Their latest funding round was raised on Apr 03, 2019 in the amount of $8.6M.
OXGENE's revenue is in the range of $10M$50M
1-888-653-2347 
support@leadiq.com